TABLE 1.
Antidiabetic Therapy | Drug Name | |
---|---|---|
Insulin | Insulin aspart, insulin aspart protamine and aspart (human), insulin detemir, insulin glargine, insulin glulisine, insulin isophane, insulin isophane and regular (human), insulin isophane (human), insulin isophane (pork), insulin lispro (human), insulin lispro protamine and lispro (human), insulin regular (human) buffered, insulin regular | |
Noninsulin medications | ||
Sulfonylureas | Chlorpropamide, glipizide, glimepiride, glyburide | |
Meglitinides | Repaglinide, nateglinide | |
Biguanides | Metformin | |
DPP-4 inhibitors | Sitagliptin, saxagliptin | |
Thiazolidinediones | Rosiglitazone, pioglitazone | |
Alpha-glucosidase inhibitors | Acarbose, miglitol | |
GLP-1 receptor agonists | Exenatide, liraglutide | |
Amylin analogues | Pramlintide | |
Combination drug products | Metaglip (glipizide/metformin); Glucovance (glyburide/metformin); Avandamet (rosiglitazone/metformin); Actoplus Met (pioglitazone/metformin); Avandaryl (rosiglitazone/glimepiride); Duetact (pioglitazone/glimepiride); Janumet (sitagliptin/metformin) |
DDP-4 = dipeptidyl peptidase-4; GLP-1 = glucagon-like peptide-1.